Legal Representation
Attorney
Yoon S. Ham
USPTO Deadlines 1 active 1 overdue
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
OPPOSITION
Notice of Publication |
NPUBE | Aug 10, 2017 | 2888 days overdue | Medium | Until Sep 10, 2017 |
Application History
45 eventsDate | Code | Type | Description |
---|---|---|---|
Oct 13, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Oct 12, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Mar 13, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Mar 12, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED |
Mar 11, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Mar 3, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Mar 3, 2020 | EXT5 | S | SOU EXTENSION 5 FILED |
Aug 14, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Aug 12, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Aug 12, 2019 | EXT4 | S | SOU EXTENSION 4 FILED |
Aug 12, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED |
Feb 14, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 12, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 12, 2019 | EXT3 | S | SOU EXTENSION 3 FILED |
Feb 12, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED |
Sep 6, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Sep 4, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Sep 4, 2018 | EXT2 | S | SOU EXTENSION 2 FILED |
Sep 4, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED |
Feb 1, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jan 30, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jan 30, 2018 | EXT1 | S | SOU EXTENSION 1 FILED |
Jan 30, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED |
Sep 5, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Jul 11, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 11, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jun 21, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jun 6, 2017 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Jun 2, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jun 2, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jun 2, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 26, 2017 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Apr 29, 2017 | CNFR | R | FINAL REFUSAL WRITTEN |
Apr 29, 2017 | GNFR | O | FINAL REFUSAL E-MAILED |
Apr 29, 2017 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
Apr 28, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Apr 28, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Apr 16, 2017 | ALIE | A | ASSIGNED TO LIE |
Apr 4, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Nov 8, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
Nov 8, 2016 | CPRA | R | PRIORITY ACTION WRITTEN |
Nov 8, 2016 | GPRA | F | PRIORITY ACTION E-MAILED |
Nov 8, 2016 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Aug 2, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Aug 1, 2016 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Research and development, laboratory and scientific research in the field of pharmaceuticals, vaccines, blood plasma preparations, recombinant proteins and antibodies
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042